series-b
Stage
2012
Founded
1
Investors
About
Axcella Therapeutics develops novel orally delivered therapeutics based on endogenous metabolic modulators to treat complex diseases by restoring metabolic function.
Explore Axcella Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.